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MAPKIt is the precise connectivity between skeletal muscles and their corresponding tendon cells to form a func-
tional myotendinous junction (MTJ) that allows for the force generation required for muscle contraction and
organismal movement. The Drosophila MTJ is composed of secreted extracellular matrix (ECM) proteins de-
posited between integrin-mediated hemi-adherens junctions on the surface of muscle and tendon cells. In
this paper, we have identiﬁed a novel, cytoplasmic role for the canonical nuclear import protein Moleskin
(Msk) in Drosophila embryonic somatic muscle attachment. Msk protein is enriched at muscle attachment
sites in late embryogenesis and msk mutant embryos exhibit a failure in muscle–tendon cell attachment. Al-
though the muscle–tendon attachment sites are reduced in size, components of the integrin complexes and
ECM proteins are properly localized inmskmutant embryos. However,mskmutants fail to localize phosphor-
ylated focal adhesion kinase (pFAK) to the sites of muscle–tendon cell junctions. In addition, the tendon cell
speciﬁc proteins Stripe (Sr) and activated mitogen-activated protein kinase (MAPK) are reduced in msk mu-
tant embryos. Our rescue experiments demonstrate that Msk is required in the muscle cell, but not in the ten-
don cells. Moreover, muscle attachment defects due to loss of Msk are rescued by an activated form of MAPK
or the secreted epidermal growth factor receptor (Egfr) ligand Vein. Taken together, these ﬁndings provide
strong evidence that Msk signals non-autonomously through the Vein-Egfr signaling pathway for late tendon
cell late differentiation and/or maintenance.cht).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Muscle development proceeds through an exquisitely regulated
series of myoblast fusion and myotube guidance events, which must
be followed by establishment of a stable myotendinous junction
(MTJ). The MTJ is the primary site for force transmission from the in-
terior of the muscle cell, across its membrane, to the extracellular ma-
trix (ECM). In healthy muscle tissue, the MTJ provides resistance
against the mechanical stress generated during muscle contraction
and allows for organismal movement. It is the precise connectivity
between skeletal muscles and their corresponding target tendon
cells that allow for the proper formation of the MTJ at muscle–tendon
attachment sites. While many features concerning MTJ formation,
structure, and function are conserved between both vertebrates and
invertebrates, studies in the genetically tractable organism Drosophila
melanogaster have proven instrumental in delineating the sequence
of events in MTJ assembly and function.
Early tendon cell induction occurs around the same time as FC
speciﬁcation, but is muscle-independent (Becker et al., 1997). The
initial pattern of tendon cell precursors are determined by signaling
pathways that pattern the epidermis, including the Wingless,Hedgehog, Notch and Egf receptor pathways (Hatini and DiNardo,
2001). This combinatorial network results in expression of the stripe
gene, which encodes for two isoforms of the epidermal growth factor
(Egf)-like transcription factor, SrA and SrB (Frommer et al., 1996;
Volk and VijayRaghavan, 1994). SrB positively maintains its own
expression and turns ectodermal cells into tendon cell precursors. In
these early differentiated tendon cells, Stripe induces the expression
of genes required in the initial steps in myotube migration. For exam-
ple, Slit is expressed in a subset of tendon cell precursors and is an
attractant for muscles that express Robo (Kramer et al., 2001).
Other guidance molecules required for extension of the ventral longi-
tudinal muscles include the muscle-expressed Perdido/Kon-tiki,
Dgrip, and Echinoid proteins (Estrada et al., 2007; Schnorrer et al.,
2007; Swan et al., 2004, 2006).
The differentiation of progenitor tendon cells into mature tendon
cells requires signaling between the newly migrated muscle cell and
corresponding target tendon cell. As myotubes approach their tar-
get tendon cells, αPS2 integrin begins to accumulate at the ends of
the muscle (Bogaert et al., 1987; Leptin et al., 1989). This integrin-
mediated adhesion is required for the localization and/or accumula-
tion of Vein, a neuregulin-like secreted ligand of the Egfr pathway
(Bogaert et al., 1987; Leptin et al., 1989; Martin-Bermudo, 2000;
Yarnitzky et al., 1997). The Egfr receptor is expressed on the surface
of tendon cells and is thought to signal through activated MAPK in
conjunction with SrA to maintain the expression of genes necessary
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lah (Dei) and β1 Tubulin (β1 Tub).
The mature MTJ is formed when fully differentiated tendon cells
are physically connected to muscles cells by ECM components,
which provide strength and elasticity for subsequent muscle contrac-
tions. Mature tendon cells secrete the ECM proteins Thrombospondin
(Tsp) and Laminin (Lam), while muscle cells make the secreted pro-
tein Tiggrin (Tig) (Bunch et al., 1998; Chanana et al., 2007; Fogerty
et al., 1994; Martin et al., 1999; Subramanian et al., 2007). It is the
association of the αPS2βPS integrin complex to the ECM components
Thrombospondin (Tsp) and Tiggrin (Tig) that participate in the mus-
cle-ECM adherens junctions at the MTJ. The tendon-ECM adherens
junctions that comprise the MTJ are mediated by the heterodimers
αPS1βPS that bind the ECM component Laminin. On the cytoplasmic
face of the integrin adherens junctions, Talin, Integrin-linked kinase
(Ilk), and PINCH function to link the membrane-bound integrin het-
erodimers to the internal actin cytoskeleton (Brown et al., 2002;
Clark et al., 2003; Zervas et al., 2001). It is the formation of this MTJ
that is essential for withstanding force contraction within a muscle
cell, as mutations in the genes that encode for the integrins, ECM
components, and cytoplasmic linker proteins Talin, and Ilk all result
in muscles that detach from the MTJs (Schweitzer et al., 2010).
We have identiﬁed Moleskin (Msk), or Drosophila Importin-7
(DIM-7, also known as RanBP7), as an essential protein for the attach-
ment of the embryonic somatic musculature. Msk is conserved in
Xenopus, Drosophila and humans, and has been well-studied for its
role in the nuclear import of proteins (Mason and Goldfarb, 2009).
Importin-7 (Imp-7) was originally identiﬁed in Xenopus where it co-
puriﬁes with Imp-β and binds the small GTPase Ran (Gorlich et al.,
1997). Imp-7 is a unique member of the Imp-β superfamily of pro-
teins. While the canonical Imp-β proteins facilitate nuclear import
by binding to both Importin-α and to the nuclear pore complex,
Imp-7 can function with and without Imp-β. For example, histone
H1 requires the Imp-β/Imp-7 heterodimer for proper nuclear import
(Jakel et al., 1999). In contrast, Imp-7 alone can directly facilitate im-
port of ribosomal proteins and the glucocorticoid receptor (Freedman
and Yamamoto, 2004; Jakel and Gorlich, 1998). However, as de-
scribed below, Msk also has functions that are independent of its
role in nuclear import.
In ﬂies, Msk/DIM-7 was identiﬁed in a yeast 2-hybrid screen as an
interacting partner of Corkscrew (Csw)/SHP2, a component of the
receptor tyrosine kinase (RTK) signaling pathway (Lorenzen et al.,
2001). Consistent with a role in the RTK signaling pathway, Msk can
bind to and transport the doubly phosphorylated, activated form of
D-ERK (dp-ERK, or MAP kinase, hereafter referred to as MAPK) into
the nucleus (James et al., 2007; Lorenzen et al., 2001). Since activated
MAPK can function in both the cytoplasm and nucleus to activate
downstream targets, the nucleocytoplasmic distribution of activated
MAPK is important for determining downstream phenotypic outputs
of the RTK pathway. For example, cytoplasmic MAPK is required for
wing vein development, while nuclear MAPK regulates cell prolifera-
tion (Marenda et al., 2006). In the developing eye, activated MAPK in
the cytoplasm is required for neuronal cell fate decisions, while acti-
vated MAPK in the nucleus controls ommatidial rotation (Vrailas
et al., 2006). In both of these developmental pathways, the availabil-
ity of activated MAPK in the cytoplasm and/or nucleus is regulated by
Msk binding to activated MAPK.
The integrin signaling pathway plays an important role in regulat-
ing Msk-dependent MAPK activation. Alleles ofmskwere identiﬁed in
a screen for dominant suppressors of an activated integrin αPS2 wing
phenotype called Blistermaker (Baker et al., 2002). Consistent with
this, Msk protein is found at the cell cortex in S2 cells where it coloca-
lizes with integrins in a Csw-dependent manner (James et al., 2007).
Furthermore, the nuclear accumulation of MAPK is compromised if
there is a reduction in Msk protein levels or decrease in integrin func-
tion. Taken together, current models suggest that Msk may be adownstream link to integrate signals between the integrin and RTK
pathways. Msk is hypothesized to be sequestered by an integrin/
Csw complex at the cell periphery. Upon activation of integrin or
RTK signaling, Msk can be phosphorylated and released from the
cell cortex to then bind dp-ERK for nuclear import (James et al.,
2007; Mason and Goldfarb, 2009).
Herein, we describe a novel role for Msk in the attachment of the
somatic musculature in Drosophila embryonic myogenesis. Embryos
mutant for msk exhibit defects in muscle attachment to tendon
cells. Consistent with this, Msk protein localizes to the sites of mus-
cle–tendon cell attachment. Intracellular proteins required for the
formation and stable adhesion of the MTJ, such as βPS int and Ilk,
are properly localized in msk mutants. Furthermore, the integrin-
interacting ECM proteins, Tsp and Tig, are secreted normally.Mskmu-
tants show a loss of phosphorylated FAK in the muscle and a loss of Sr
and activated MAPK in the tendon cells.
Reintroduction of Msk in the muscle or activated MAPK in the ten-
don cells in a msk mutant background restores muscle–tendon at-
tachment. We also found that Vein functions downstream of Msk to
activate the Egfr pathway in the tendon cells. We propose a model
where Msk is essential for cell signaling from the muscle to the ten-
don cell to mediate proper muscle–tendon attachment and possibly
MTJ maintenance.
Materials and methods
Genetics
Fly stockswere raised on standard cornmealmediumat 25 °C unless
otherwise indicated. Oregon R or y,wwas used as the wild-type strain.
The following ﬂy stocks and/or alleles were used in this study: msk2/
TM3-lacZ and msk4/TM3-lacZ [a gift from Lizabeth Perkins; (Baker
et al., 2002)]; Ilk-GFP [a gift from Julie Kadmras; (Clark et al., 2003)];
mef2-GAL4 [(Geisbrecht et al., 2008)]; UAS-MAPKWT and UAS-MAPKSEM
[a gift from Jessica Triesman; (Roignant and Treisman, 2010)]; and
UAS-Vein [a gift from Talia Volk; (Yarnitzky et al., 1997)]. The following
stocks were obtained from the Bloomington Stock Center: w; msk5 P
{neoFRT}80B/TM3, P{ftz-lacZ.ry+}TM3, Sb1 (BL-23879), Df(3L)66c-28/
TM3, Sb (BL-1541); MTD-GAL4; sr-GAL4/TM6 (BL-26663); en-GAL4
(BL-6356); and sim-GAL4 (BL-9150). The following stocks were gen-
erated by standard meiotic recombination and veriﬁed by complemen-
tation and/or PCR: msk5, UAS-msk (for rescue); mef2-GAL4; msk4 (for
rescue); sr-GAL4; msk4 (for rescue), ilk-GFP, msk4; UAS-MAPKWT, msk5
(for rescue); UAS-MAPKWT, msk4 (for rescue); UAS-MAPKSEM, msk5 (for
rescue); UAS-MAPKSEM, msk4 (for rescue); and UAS-Vein, msk4 (for
rescue).
In situ hybridization and immunostaining
Embryoswere collected on agar-apple juice plates and aged at 25 °C.
For immunostaining, embryos were ﬁxed and stained as described
(Geisbrecht et al., 2008). Primary antibodies used were: anti-MHC
(1:500, Susan Abmayr); anti-Msk [1:1000, (Lorenzen et al., 2001)];
anti-TM (1:50, The Babraham Institute, Cambridge, UK); anti-Mef2
[1:1000, (Bour et al., 1995)]; βPS-integrin (1:50, Developmental
Studies Hybridoma Bank (DSHB), University of Iowa); anti-Talin E16B
(1:20, DSHB, University of Iowa); anti Tig [1:1000, (Fogerty et al.,
1994)]; anti-Tsp [1:500, (Subramanian et al., 2007)]; anti-GIT1 [1:500,
(Bahri et al., 2009)]; anti-FAK[pY397] (1:1000, Invitrogen); anti-dp-
ERK/MAPK (1:100, Sigma); anti-Sr [1:200; (Frommer et al., 1996)].
Secondary antibody used for immunohistochemistry was goat
anti-mouse-HRP (1:200, Jackson). Secondary antibodies for ﬂuorescent
immunostaining were Alexa Fluor 488 or Alexa Fluor 546 (1:400,
Molecular Probes, Carlsbad, CA). Phalloidin 546 was used for F-actin
labeling. Tyramide enhancement was used to improve signals for anti-
Msk, anti-GIT1, and anti-dp-ERK-MAPK (Invitrogen, Carlsbad, CA).
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Molecular biology
The ORF of the msk cDNA was cloned into the entry vector
(Drosophila GATEWAY™ cloning system, Invitrogen) in the proper
reading frame. Msk-YFP fusions were generated using the pTVW
and pTWV gateway destination vectors (pUAST-based vector, EYFP
fusions at either end) using the Drosophila Gateway Cloning System
according to the instruction manual and injected via Genetic Services,
Inc.
Results
Drosophila moleskin mutants exhibit defects in embryonic muscle
attachment
We undertook a proteomics approach to identify new proteins
that may be required in the development of the Drosophila embryonic
somatic musculature (Geisbrecht et al., 2008). One protein that was
uncovered using this approach was Drosophila Importin-7 (DIM-7),
also known as Moleskin (Msk). Other proteins identiﬁed in this
screen will be published elsewhere.Fig. 1.Mskmutant embryos exhibit defects in somatic muscle attachment. (A–C) Schematic
culature. (D–O) The dorsal (D, G, J, M), lateral (E, H, K, N), and ventral (F, I, L, O) musculatu
Wild-type embryos exhibit a stereotypical repeating pattern of muscles in each hemisegmen
cle attachment defects (Class I) that affect all muscle subsets (12.1%; n=33). (J–L) The tran
bryos show moderate defects in muscle attachment (Class II). (M–O) msk4 over a deﬁcien
penetrance. In all embryos, anterior is to the left. Scale bar: 20 μm.To determine whether there is a signiﬁcant role for Msk in the
development of the somatic musculature, we examined the muscle
phenotypes of trans-heterozygous combinations of available msk
alleles (Baker et al., 2002). After stage 16,msk2/msk4 mutant embryos
stained with anti-Myosin heavy chain (MHC) exhibited an aberrant
muscle pattern, predominantly characterized by missing muscles
(12.1%, n=33) and/or muscles that were not positioned correctly
(57.6%). Upon closer examination, the apparent muscle positioning
phenotypes fell into two classes: either severe (Class I) or moderate
(Class II) muscle attachment defects. A representative example of
the Class I severe phenotype is shown in Figs. 1G–I, where 12.1% of
the embryos of this genotype had muscles that were completely de-
tached from the epidermis and “balled” up. 45.5% of the homozygous
msk2/msk4 embryos (termed Class II) showed muscles that were for
the most part correctly positioned, but at least one end of the muscle
failed to attach correctly to the corresponding epidermal attachment
site (Figs. 1J–L). Similar phenotypes were observed inmsk4/msk5 mu-
tant embryos, where 12.5% of the embryos exhibited the weaker at-
tachment defects, while 44.6% revealed severe attachment defects
(n=56). These muscle defects affected all muscle subsets, as the
same phenotypes were observed in the dorsal (Figs. 1G, J, M), lateral
(Figs. 1H, K, N) and ventral (Figs. 1I, L, O) muscle groups. All msk al-
leles we analyzed contain mutations that result in Msk protein trun-
cations and are predicted to be genetically null alleles (Baker et al.,illustration of the WT muscle pattern in the dorsal (A), lateral (B) and ventral (C) mus-
re in stage 17 embryos visualized immunohistochemically with MHC antibody. (D–F)
t. (G–I) Embryos trans-heterozygous for themsk2 and msk4 alleles exhibit severe mus-
s-heterozygous combination msk2/msk4 shows variable penetrance as 45.5% of the em-
cy that removes the msk locus also exhibits muscle attachment defects with variable
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tachment phenotypes did not increase in embryos trans-heterozy-
gous for either msk5 (data not shown) or msk4 and the deﬁciency
line, Df(3L)66c-28 (Figs. 1M–O), which removes the entire msk locus.
The residual muscle–tendon association observed in the Class II
embryos is likely due to the presence of maternal Msk.Msk transcript
and protein are observed in early Drosophila 0–2 h embryos before
zygotic transcription has begun (data not shown). Consistent with
the presence of maternal Msk, the formation of ventral acute muscle
2 (VA2) occurs normally in msk homozygous embryos (Johnson
Hamlet and Perkins, 2001). To assess if removal of maternal Msk in-
creased the severity of the muscle detachment phenotypes, we uti-
lized germline clone analysis (GLC). GLC analysis of the null msk5
allele does not result in viable eggs as Msk is required for cell growth
(Baker et al., 2002). Therefore, we generated ﬂies of the genotype
FRT2A, msk1 for GLC analysis with the expectation that the predicted
hypomorphic msk1 allele may be sufﬁcient to knockdown msk func-
tion, yet allow the animals to survive until late embryogenesis
when the musculature could be examined. However, female ﬂiesFig. 2.Muscle cell fate and myotube migration are not affected in msk mutant embryos. (A–
Similar numbers of Mef2-expressing myoblasts are observed inWT (A, B) andmsk4/msk5 hom
D). (E, F) Confocal micrographs of the ventral musculature in stage 15 embryos stained with
muscles have migrated to the site of muscle–tendon attachment. (F) The ability of the ventr
heads denote muscle–tendon attachment sites and arrows point to unfused myoblasts still p
bars: 50 μm in A, C; 20 μm in B, D; 10 μm in E, F.from these experiments did not produce embryos and subsequent
dissection of the resulting ovaries showed severe atrophy (data not
shown). This result suggests Msk is required in oogenesis, and/or
that the predicted msk1 allele may be stronger than a weak allele.
Our phenotypic analysis indicates that msk mutants exhibit pleio-
tropic defects in muscle development, including muscle patterning
and muscle detachment phenotypes. Therefore, we sought to deter-
mine whether these defects may be due to an earlier role in muscle
cell fate commitment or the migration of myotubes to their target
sites of attachment. Mef2 is a transcription factor expressed in the
early mesoderm and its expression is maintained throughout em-
bryogenesis in different muscle cell lineages. Consistent with a cen-
tral role in muscle development, both genetic analysis of mef2
mutants and enhancer studies show that Mef2 is required for multi-
ple myogenic events, including myoblast fusion and the regulation of
muscle identity genes (Potthoff and Olson, 2007; Sandmann et al.,
2006). In wild-type embryos, Mef2 protein is apparent in the nuclei
of developing muscles in stage 13 and 14 embryos (Figs. 2A, B).
Similar numbers of Mef2-positive muscle cells were observed inD) Immunoﬂuorescent stainings of stage 13 (A, C) and stage 14 (B, D) embryos. (A–D)
ozyogous embryos (C, D) in both the lateral (A, C) and ventral longitudinal muscles (B,
a monoclonal antibody to MHC. (E) By stage 15 in WT embryos, the ventral longitudinal
al muscles to ﬁnd their proper attachment sites is not affected in mskmutants. Arrow-
resent in stage 15 embryos. In all embryos, anterior is to the left and dorsal is up. Scale
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consistently missing in the small percentage of msk mutant embryos
that exhibit patterning defects, or missing muscles (12.1%), suggest-
ing that Msk affects all muscles. By stage 15 in myogenesis, the
wild-type muscles that reach their corresponding muscle–tendon-at-
tachment site are positioned properly for MTJ assembly (Fig. 2E). This
process is not affected in msk mutants as elongated myotubes are
observed at the segment borders of the ventral longitudinal muscles
in stage 15 embryos (Fig. 2F). These data taken together strongly sug-
gest the muscle attachment defects in msk mutants are not due to
earlier defects in cell fate speciﬁcation or migration of the muscles
to their target tendon cells.
Msk is required in muscles cells, but not the tendon cells, for proper
muscle–tendon attachment
Cell–cell signaling between the muscle cells and their correspond-
ing tendon cells is critical for proper muscle–tendon attachment
(Schweitzer et al., 2010). To identify whether Msk is required in the
muscle and/or tendon cells for proper muscle attachment, we per-
formed tissue-speciﬁc rescue experiments using the GAL4/UAS
system. We expressed UAS-msk in the tendon cells of msk trans-
heterozygous embryos using the sr-GAL4 driver. No rescue of the
muscle attachment defects in msk4/msk5 embryos were observed
(compare Figs. 3A to B). Next, we used the mef2-GAL4 driver to
express UAS-msk in all muscle cells. The resulting phenotypes were
divided into four classes, based upon the severity of the muscle de-
fects (Fig. 3F). Class I embryos were characterized by severe muscle
detachment phenotypes, including embryos of the genotype msk4/Fig. 3. Msk is required in muscle cells for proper muscle–tendon attachment. (A–E) MHC st
sentative embryo of the genotype msk4/msk5 shows severe defects in muscle attachment w
Expression of Msk in either the tendon cells (B) or the muscle cells (C–E) inmsk4/msk5 emb
GAL4 does not rescue the muscle attachment defects (Class I). (C–E) Expression of UAS-msk
(C; Class II), minor patterning defects (D; Class III), or rescue to a WT muscle pattern (E; Cl
partially (Class II; 15.5%) or fully (Class IV; 64.5%) rescue the muscle attachment defects in
expression of Msk in the tendon cells and exhibit phenotypes quantitatively similar to thatmsk5 that failed to be rescued by the expression of sr-GAL4 in the ten-
don cells (Figs. 3A, B). However, expression of UAS-msk bymef2-GAL4
resulted in either partial rescue of attachment defects (Fig. 3C; Class
II), or complete rescue to a WT muscle pattern (Fig. 3E; Class IV).
Some of the embryos rescued by mef2-GAL4::UAS-msk in a msk4/
msk5 mutant background exhibited minor patterning defects, but no
muscle attachment defects (Fig. 3D; Class III). These experiments sug-
gest the muscle-speciﬁc expression of Msk is essential for its function.
Msk protein is enriched at muscle attachment sites
Our phenotypic analysis suggests that Msk functions in muscle tis-
sue during the later stages of myogenesis to mediate muscle–tendon
cell attachment. We examined the distribution of Msk protein
throughout embryogenesis to gain a better understanding of the
role of Msk in this process. Consistent with previous results (Lorenzen
et al., 2001), Msk is dynamically expressed in early to mid embryonic
development and can be found in either the nucleus or cytoplasm
(Fig. 4A; data not shown). Immunostaining with antisera generated
against the Msk protein (Lorenzen et al., 2001) in stage 16 embryos
showed a strong accumulation of Msk protein at the segment borders
where muscles connect to tendon cells (Fig. 4B). This staining pattern
was present in the dorsal, lateral and ventral muscle groups and was
not detected in msk4/msk5 mutant embryos (Fig. 4C). To conﬁrm and
extend our observation that Msk protein is enriched at sites of mus-
cle–tendon attachment, we generated an N-terminal YFP-Msk fusion
protein under control of the GAL4/UAS system. Using the early MTD-
GAL4 driver, YFP-Msk was found in the nucleus in late blastoderm
stage embryos (Fig. 4F). This localization nicely recapitulated theaining of 3 hemisegments of the lateral musculature in stage 17 embryos. (A) A repre-
here muscles have pulled away from attachment sites and are found in a “ball.” (B–E)
ryos using the GAL4/UAS system. (B) Expression of UAS-msk in the tendon cells using sr-
in the muscle under control of the mef2 promoter results in minor attachment defects
ass IV). Scale bar: 20 μm. (F) A bar graph quantitating the ability of mef2-GAL to either
msk4/msk5 embryos (n=110). In contrast, embryos with sr-GAL4 are not rescued by
of msk4/msk5 mutants only. Scale bar: 20 μm.
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embryos (Fig. 4A)(Lorenzen et al., 2001). In addition, the subcellular
distribution of YFP-Msk in Drosophila S2 cells appeared identical to
Msk protein localization using antisera raised against Msk protein
(Supplementary Figs. S1A–C) (James et al., 2007). Coincident with
the process of myoblast fusion in stage 14 embryos, YFP-Msk expres-
sion was observed in both the nucleus and cytoplasm of the devel-
oping myotubes (Fig. 4G), although the signiﬁcance of the nuclear
expression is unclear. In the somatic musculature by stage 14, βPS
integrin (βPS int) accumulation can be observed at the muscle attach-
ment sites (Bogaert et al., 1987). However, we could not detect Msk
protein by antibody staining (Fig. 4D) or YFP-Msk fusion protein
enrichment at the site of the future MTJs, where βPS int is clearly pre-
sent (Figs. 4I–I′). Consistent with our genetic data that Msk is re-
quired after stage 15 for muscle attachment, we ﬁrst observed Msk
protein at muscle attachment sites in stage 16 embryos (Fig. 4E).
This localization persisted in stage 17 embryos, where colocalization
with βPS int was apparent (Figs. 4J–K″). The appearance of Msk pro-
tein at the muscle–tendon attachment sites at the beginning of stage
16 in myogenesis strongly suggests Msk is required for the differenti-
ation and/or maintenance, but not initiation of MTJ formation.
Integrin and ECM components are properly localized in msk mutant
embryos
The enrichment ofMsk protein at the sites ofmuscle–tendon cell at-
tachments and the detachment of the somatic muscles in msk
mutant embryos raised the possibility that integrin-mediated muscle–
tendon adhesion is defective in msk mutant embryos. To examine this
inmore detail, we focused our analysis on the ventral longitudinal mus-
cles, where the MTJ sites are large and easily observed (Fig. 1C). Here,
βPS integrins are expressed at the ends of the ventral muscles and the
basal side of the tendon cells tomake contact with ECM proteins depos-
ited between themuscle and tendon cells (Figs. 5A–A″). Inmskmutants,Fig. 4. Msk protein localizes to muscle–tendon attachment sites in late stage embryos. (A–E
antisera. (A) Msk protein is nuclear in late blastoderm embryos. (B–E) Msk protein is in gree
at the dorsal, lateral and ventral muscle–tendon attachment sites in stage 16 embryos. (C) M
is not observed at the ventral muscle-attachment sites in stage 14 embryos (D), but is observ
Msk-YFP (green). Expression of MTD-GAL4::Msk-YFP in late blastoderm embryos (F) and m
localization (F) mimics the nuclear Msk protein expression (A). YFP-Msk protein is detect
becomes enriched at the ends of muscles in the latter stage (arrowhead in H). (I′, J′, K′) D
site in the ventral musculature. YFP-Msk expression occurs throughout the muscle, but is n
YFP-Msk protein is enriched at the sites of muscle attachment and colocalizes with βPS-intβPS int was still localized to the correct positions at the segment
borders of the ventral muscles (Figs. 5B–B″). We never observed βPS
int expression at the ends of muscles that had already detached
(arrows). However, the domain of βPS int expression was reduced
in size compared to WT embryos (compare line in Figs. 5A′ to 5B′).
To further elucidate the role of Msk in muscle attachment at the
MTJ, we examined the distribution of the cytoskeletal proteins ILK
and Talin. Both of these proteins function to link the cytoplasmic do-
main of integrins to the actin cytoskeleton within the muscle cell.
Like βPS int, ILKwas still expressed and localized to the correct location
in mskmutants that exhibited either moderate (Figs. 5D–D″) or severe
(Figs. 5E–E″) attachment defects. Consistent with the results obtained
for both βPS int and ILK, immunostaining against Talin revealed it
was also correctly localized (Supplementary Figs. S2A–B′). Mutations
in mys (βPS int) or rhea (Talin) show adhesion defects that result
from detachment of the cell membrane from the ECM, while Ilk,
PINCH, or partial loss-of-function αPS2 int mutants are characterized
by detachment of the actin cytoskeleton from the muscle cell mem-
brane (Brown, 1994; Clark et al., 2003; Leptin et al., 1989; Newman
and Wright, 1981; Zervas et al., 2001). To investigate if a defect in
actin tethering to the muscle cell membrane is responsible for the de-
tachment phenotype observed inmskmutants, we labeled the mutants
with phalloidin to visualize F-actin ﬁlament organization. Both WT
(Fig. 5F) and msk4/msk5 mutants (Fig. 5G) stained strongly for actin.
In addition, numerous F-actin based structures extended across the en-
tire muscle ﬁlament and accumulated normally at the sites of attach-
ment in both genotypes.
The muscle-speciﬁc αPS2βPS integrin heterodimer that localizes
to the ends of the muscles interacts with the ECM proteins Tsp and
Tig, secreted from the tendon cells and muscles, respectively (Bunch
et al., 1998; Chanana et al., 2007; Fogerty et al., 1994; Subramanian
et al., 2007). To determine whether the observed muscle defects are
a result of improper ECM secretion and/or localization, we examined
msk mutant embryos for Tsp and Tig protein distribution. In WT) Msk protein expression and localization in embryogenesis visualized using anti-Msk
n and muscle is labeled in red using anti-Tropomyosin (TM). (B) Msk becomes enriched
sk attachment site staining is absent inmsk4/msk5 mutant embryos. (D, E) Msk protein
ed after stage 15 (E). (F–K′) Msk protein expression visualized using the fusion protein
ef2-GAL4::Msk-YFP in stage 16 embryos (G–K′). The Msk-YFP protein expression and
ed in both the nucleus and cytoplasm in stage 14 (G) and stage 16 (H) embryos, but
ouble labeling with βPS-integrin (red) shows the location of the muscle attachment
ot enriched near βPS-integrin in stage 15 embryos (panels I, I′). In stage 17 embryos,
(panels J′, K′; arrowheads). Scale bars: 50 μm in A–D; 20 μm in E–H′; 10 μm in I–I′.
Fig. 5. Components of integrin-mediated adherens junctions localize to the correct positions inmskmutant embryos. (A–G) Immunoﬂuorescent stainings of stage 17 embryos. Ventral
musculature with anterior to the left and dorsal up. (A–B″) βPS-integrin staining in WT embryos localizes to the ends of muscles where they form contacts with tendon cells (A–A″).
Msk mutants have correctly positioned, but smaller muscle attachment sites (compare vertical white bars) as demonstrated by βPS-int staining (B′–B″). (C–D″) Ilk-GFP also localizes
to muscle attachment sites inWT (C′–C″). Inmskmutants, Ilk-GFP is present at the correct place, although altered in size, in embryos that exhibit mild (D′–D″) or severe (E′–E″) muscle
attachment defects. (F, G) Phalloidin labeling reveals F-actin ﬁlaments that span eachmuscle and accumulate at the ends ofmuscles in bothWT (F) andmsk (G)mutants. Arrows point out
muscles that have detached. Scale bar: 20 μm.
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calization are similar to that of βPS-integrin at the MTJ. In msk mu-
tants, both Tig (Figs. 6B–B″) and Tsp (Figs. 6D–D″) are still present,
although reduced in size. These results taken together suggest the
defects underlying the muscle detachment phenotype observed in
mskmutants are not due to general defects in either the extracellular
or cytoplasmic face of integrin-mediated adherens junctions.
Msk is required for pFAK localization to the muscle attachment sites
GIT1 is an adapter protein in mammals that associates with com-
ponents of focal adhesion complexes to modulate focal adhesion dis-
assembly and cell motility (Bahri et al., 2009). In late stage embryos,
GIT1 localizes to muscle attachment sites and can be visualized at
the tips of myotubes (Figs. 7A′–A″). In msk mutants, GIT1 expression
was still present and properly localized to muscle attachment sites
(Figs. 7B′–B″). Interestingly, GIT1 expression was also upregulated
at the ends of the ventral muscles, although the signiﬁcance of this
is yet unclear. In response to integrin activation, the vertebrate
non-receptor tyrosine kinase focal adhesion kinase (FAK) binds to
the cytoplasmic tail of integrins (Grabbe et al., 2004). FAK becomes
activated upon phosphorylation and can then interact with GIT1 inmammalian systems (Zhao et al., 2000). An antibody generated
against the mammalian phosphorylated FAK (pFAKY397) protein
cross-reacts with the phosphorylated form of Drosophila FAK (pFAK)
and is strongly localized to embryonic muscle attachment sites
(Figs. 7C′–C″), (Grabbe et al., 2004). Surprisingly, pFAK expression
was undetectable in all mskmutant embryos examined (Figs. 7D′–D″).
However, no increase and/or abnormal localization of pFAK is observed
in embryos overexpressing Msk in the musculature (data not shown),
suggesting that Msk is not sufﬁcient for pFAK localization.
Msk is necessary, but not sufﬁcient for tendon cell induction
Muscle attachment is complete when the muscle-speciﬁc
αPS2βPS integrin heterodimer and tendon-speciﬁc αPS1βPS integrin
heterodimer form a mature MTJ with ECM proteins deposited be-
tween the two cells types (Schweitzer et al., 2010). After initial ten-
don cell induction by SrB in stage 11–12 embryos, SrA is activated
at a later developmental stage to turn on transcription of genes re-
quired for muscle targeting to tendon cells, including slit and Tsp.
The smaller attachment sites observed with Tsp immunolocalization
in msk mutant embryos is phenotypically similar to that Tsp staining
in sr155/srDG4 embryos (Subramanian et al., 2007). To examine if the
Fig. 6. The ECM proteins Tig and Tsp are secreted and localized to muscle attachment sites. (A–D″) Ventral musculature with anterior to the left and dorsal up. (A–D″) The ventral
musculature (red) in stage 16 embryos stained with ECM proteins (green). (A–B″) Tig is enriched at muscle–muscle attachment sites in wild-type embryos (A–A″). The localization
and expression of Tig is still present inmskmutant embryos, although the size of the attachment site is reduced (B–B″). (C–D″) Tsp is enriched at muscle–tendon attachment sites in
both wild-type (C–C″) and msk mutant embryos (D–D″). As with Tig, there is a reduction in the size of the attachment sites. Scale bar: 20 μm.
Fig. 7.Msk is required for pFAK localization. (A–D″) Immunoﬂuorescent stainings of stage 17 embryos. A–D″ are views of the ventral musculature with anterior to the left and dorsal
up. (A–B″) GIT1 properly localizes to muscle attachment sites in both WT (A′–A″) and msk mutant embryos (B′–B″). Phosphorylated FAK, normally present at the sites of muscle–
tendon attachments (C′–C″), is absent in all msk mutants examined (D′–D″). Arrows indicate detached muscle. Scale bar: 20 μm.
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184 Z.(C.) Liu, E.R. Geisbrecht / Developmental Biology 359 (2011) 176–189aberrant muscle attachment defects in msk mutants could be due to
aberrant tendon cell function, we examined the expression of Sr, a
transcription factor that is required for the induction and mainte-
nance of tendon cell fate. Sr is normally expressed in all tendon
cells in late stage WT embryos (Figs. 8A–A″). In msk mutants, Sr
expression is severely reduced and observed occasionally in only a
few tendon cells (Figs. 8B–B″).Fig. 8.Msk is necessary, but not sufﬁcient for tendon cell induction. Immunoﬂuorescent sta
found in all mature tendon cells in stage 16 embryos (A′–A″). A decrease in Msk levels results
of YFP-Msk in the musculature with mef2-GAL4 results in either a WT muscle pattern (Fig
as visualized by βPS-integrin staining (C–D″). (E–F′) βPS-int is present at the ends of mu
(F, F′). (G–G′) Expression of YFP-Msk in all epidermal cells under control of the engrailed pro
is left and dorsal is up. All panels are representative embryos of ventral muscles. Scale barsEctopic expression of Sr in a WT background results in mild
aberrations of the normal muscle pattern. When Sr is induced by
engrailed-GAL4 (en-GAL4) or patched-GAL4 (ptc-GAL4), the lateral mus-
cles are either missing or connected to cells ectopically expressing Sr
(Frommer et al., 1996; Volk and VijayRaghavan, 1994). To examine if
ectopic expression of Msk in either the muscle or epidermis could phe-
nocopy that of ectopic Sr induction, we expressed UAS-YFP-Msk or UAS-inings. Ventral musculature with anterior to the left and dorsal up. (A–B″) Sr protein is
in a dramatic decrease in Sr protein (B′–B″). Muscle is shown in red. (C–D″) Expression
. 4H) or muscles that appear pointed at the ends and have smaller attachment sites
scles in stage 14 embryos in WT (E, E′) and in muscles that are over-expressing Msk
moter shows muscles (red) with aberrant muscle attachments. In all examples, anterior
: 20 μm in A–C; 10 μm in D–D′; 50 μm in G–G′.
185Z.(C.) Liu, E.R. Geisbrecht / Developmental Biology 359 (2011) 176–189Msk (data not shown) in either tissue. 73.6% of the embryos of the geno-
type mef2-GAL4::UAS-YFP-Msk (n=19) showed a WT muscle pattern
(Fig. 4H). In the other 26.3% of the mef2-GAL4::UAS-YFP-Msk embryos,
the ventral longitudinal muscles were attached at the correct locations,
but exhibited abnormal attachment sites (Fig. 8C). However, in these
embryos, Sr expression was not signiﬁcantly different from WT (Sup-
plementary Figs. S3A–A″) andwas not induced or upregulated at earlier
stages (data not shown). High magniﬁcation views of representative
embryos show the muscles appear pointed at the muscle ends and re-
sult in small, round attachment sites as visualized by colocalization
with βPS-integrin (Figs. 8D, D′). This phenotype is reminiscent of em-
bryos that havemutations in the slowdown (slow) gene, which encodes
a secreted protein essential for MTJ assembly. In slow mutants, βPS-
integrin, Talin, and Tsp accumulate prematurely at the ends of migrat-
ing muscles (Gilsohn and Volk, 2010). Therefore, we examined if the
premature accumulation and/or localization of βPS int could be one
mechanism for the pointed muscles that end in small attachment sites
in embryos that over-express Msk. We analyzed stage 14 embryos
expressing YFP-Msk and found that the accumulation of βPS int at the
ends of migrating muscles was similar to that in WT embryos
(Figs. 8E–F′). Surprisingly, expression of YFP-Msk by en-GAL4 in the epi-
dermis also resulted in muscle attachment defects (Figs. 8E–E′; 42.4%;
n=33). However, as in en-GAL4::UAS-Sr embryos (Frommer et al.,
1996; Volk and VijayRaghavan, 1994), we never observed mis-
migration of the muscles or aberrant attachment to ectopic Msk-
expressing cells. We were not able to induce abnormal migration of
muscles to either the salivary glands (Supplementary Figs. S3B–B″) or
toward the CNS (Supplementary Figs. S3C–C″) by ectopic expression
of YFP-Msk using sim-GAL4. These results taken together support a
model where Msk may be necessary for tendon cell differentiation,Fig. 9.MAPK and Vein act downstream of Msk to mediate muscle–tendon attachment. (A–C‴)
embryos, MAPK is present in the tendon cells and extends the length of the ventral muscles a
muscle–tendon attachment sites. (C–C‴) The number of tendon cells that show activated MAP
staining. (D) Severe attachment defects are observed in msk4/msk4 embryos (Class I). Expres
with mild attachment defects (E; Class II), patterning defects (F; Class III), or complete rescue
in smaller attachment sites (compare to panels A–A‴) and reduced MAPK staining (H) or se
(I). (J) Bar graph that quantitates the rescue of muscle attachment defects inmsk4/msk5 orms
all examples, anterior is left and dorsal is up. All panels are representative embryos of ventralbut is not sufﬁcient to induce Sr expression. Our data suggests that the
detached muscles and smaller attachment sites present in embryos
that over-express Msk do not result from the early accumulation of
Integrin complexes or abnormal upregulation of Sr expression.
Msk signals to the tendon cells for normal MAPK function
The Egfr pathway signals through the activated form of MAPK in
tendon cells (Martin-Bermudo, 2000). To test if Msk affects the acti-
vation of MAPK in muscle–tendon attachment, we used an antibody
that recognizes the activated form of MAPK (Gabay et al., 1997). In
WT embryos, we observed MAPK in the tendon cells (Figs. 9A–A‴).
In contrast, we could not detect activated MAPK in the tendon cells
of msk mutant embryos (Figs. 9B–B‴). Furthermore, expression of
excess Msk in the muscle resulted in a reduction in the number of
MAPK-expressing tendon cells (Figs. 9C–C‴). This suggests that prop-
er levels of Msk are necessary to regulate activated MAPK in the
tendon cells. To test if MAPK functions downstream of Msk, we
expressed both the wild-type and activated (SEM) forms of MAPK
in a msk mutant background. Expression of both forms of the MAPK
protein in tendon cells using sr-GAL4 rescued the msk muscle attach-
ment defects (Fig. 9J). The severe muscle attachment phenotype ob-
served in msk4/msk5 mutant embryos (42.8%; n=56) was reduced
to only 2.4% of the embryos when UAS-MAPKWT was reintroduced
into the tendon cells (n=84). The activated form of MAPK, (UAS-
MAPKSEM) resulted in stronger rescue of the attachment phenotype,
where 67.0% of the embryos were restored to WT (n=130) com-
pared to only 42.3% of WT embryos in the control genotype (msk4/
msk5; n=56). We wanted to verify the ability of MAPK to rescue
msk mutants in a different genetic background. We chose to rescueImmunoﬂuorescent stainings of muscle (red) and activated MAPK (green). (A–A‴) InWT
t the segment borders. (B–B‴) Inmskmutants, activated MAPK cannot be detected at the
K staining is reduced in embryos that over-express Msk in the musculature. (D–G) MHC
sion of activated MAPK (MAPKSEM) in the tendon cells using sr-GAL4 results in muscles
to a WT muscle pattern (G; Class IV). (H, I) Expression of Vein in the musculature results
vere attachment defect and a complete loss of activated MAPK at the attachment sites
k4/msk4 mutant embryos upon over-expression of WT MAPK, activated MAPK, or Vein. In
muscles. Scale bars: 20 μm in A–G; 10 μm in H–I.
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in these embryos were more severe, where 51.6% of the embryos
showed a severe attachment phenotype (Fig. 9D). Similar rescue
trends were observed when we expressed UAS-MAPKWT or UAS-
MAPKSEM in the msk4 background. The percentage of embryos that
exhibited severe muscle attachment defects were to reduced 5.0%
and 3.2% upon tendon-cell speciﬁc expression ofMAPKWT orMAPKSEM,
respectively (Fig. 9J).
Msk is postulated to integrate downstream signals from both the
Egfr and integrin signaling pathways to regulate the subcellular local-
ization of MAPK (James et al., 2007; Mason and Goldfarb, 2009).
Integrins are required to promote the proper localization and/or accu-
mulation of the secreted Egfr ligand, Vein (Martin-Bermudo, 2000).
We therefore tested if Vein signaling could be one mechanism by
which the muscle-expressed Msk maintains tendon cell function. As
previously reported (Yarnitzky et al., 1997), we observed that over-
expression of Vein in the muscle occasionally resulted in ectopic ten-
don cells. But we also found embryos with smaller attachment sites
and mild muscle attachment defects (39.3%; n=61). In these same
embryos, there was a reduction in the number of tendon cells with
activated MAPK (Fig. 9H). This phenotype was similar to that ob-
served with the over-expression of Msk in the muscle (Figs. 9C–C‴).
Furthermore, severe muscle attachment defects and a loss of activat-
ed MAPK were seen in 21.3% of the embryos (Fig. 9I; n=61). We
were able to rescue the severe msk4/msk4 muscle attachment defects
by expressing UAS-Vein in either the muscle or tendon cells (Fig. 9J).
Tendon cell expressed-Vein rescued better than muscle-expressed
Vein, presumably because secreted Vein was in closer proximity to
the tendon cells expressing its Egf receptor. Collectively, these data
suggest a model where Msk signals to the tendon cell via the secreted
Egfr ligand Vein to inﬂuence activated MAPK signaling in the tendonFig. 10.Model of Msk function at the muscle–tendon attachment site. (A) In WT embryos, m
(shown in blue) between the cells. Msk is required in the muscle and functions via secreted
vates a signaling cascade through activated MAPK. Activated MAPK translocates to the nucl
tendon cells. Tight association of the muscle-expressed αPS2βPS integrin heterodimer to E
contraction. Msk may directly affect Vein secretion, accumulation and/or localization at the
indirectly by modulating integrin-mediated adhesion. This adhesive function is required fo
Msk on integrin-mediated adhesion may be direct or occur via phosphoproteins such as pFA
role(s) of Msk based upon our results. (B) In msk mutants, the ECM matrix (blue) is reduc
Terminal tendon cell differentiation does not occur as Sr and activated MAPK are dramaticall
in smaller attachment sites. Within the muscle cells, pFAK is absent. Here, dotted lines andcells. A loss of this signaling results in fewer tendon cells with activat-
ed MAPK activity, smaller attachment sites, and the inability of ten-
don cells to maintain proper muscle–tendon attachment.Discussion
In Drosophila, the formation of a stable myotendinous junction is
essential to withstand the force of muscle contraction required for
larval hatching. Proper formation of the MTJ requires proper integrin
heterodimer formation at the junctions between both muscle cells
and tendon cells for a permanent linkage to the ECM proteins depos-
ited between these two cell types. The precise mechanism by which
the muscle cells signal to the tendon cells to form and maintain the
semi-adherens junctions that comprise the stable MTJ is still being
elucidated. Here, we show that the canonical nuclear import protein
Msk is essential for Drosophila somatic muscle attachment. Moreover,
we provide a model explaining how Msk may function in non-cell
autonomously from the muscle to the tendon cell for proper MTJ
maintenance. Though vein mRNA is produced in the myotubes, Vein
protein is secreted and is restricted to the junctions at muscle–tendon
attachment sites (Yarnitzky et al., 1997). As shown in Fig. 10, Msk sig-
nals through the secreted Egfr ligand Vein to mediate cross-talk
between the muscle and tendon cells. The binding of Vein to the
tendon-expressed Egfr activates a signaling cascade through activat-
ed MAPK. Activated MAPK translocates to the nucleus and with SrA,
activates downstream genes to induce terminal differentiation in
the tendon cells. An inability of the tendon cells to maintain activated
MAPK and Sr activity would affect the amounts of target proteins
required to maintain stable muscle–tendon adhesion. For example, a
decrease in Tsp deposition into the ECM would result in smallerature muscles associate with their corresponding tendon cells via an ECM-rich matrix
Vein to affect tendon cell function. Binding of Vein to the tendon-expressed Egfr acti-
eus and with SrA, activates downstream genes to induce terminal differentiation in the
CM proteins (such as the SrA target Tsp) is essential to withstand the force of muscle
site of the muscle–tendon attachment site. Alternatively, Msk may affect Vein activity
r Vein to properly activate the Egfr signaling pathway in the tendon cells. The effect of
K. Solid arrows denote previously published studies. Dotted arrows represent potential
ed in size and the muscle is no longer attached at the muscle–tendon attachment site.
y reduced. Subsequently, Tsp expression and secretion is reduced, presumably resulting
arrows denote a loss of protein and/or function due to a decrease in Msk protein.
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association.
Msk plays a general role inmyogenesis as defects inmskmutant em-
bryos were observed in all hemisegments and affected all muscle
groups. The variable penetrance, which we classiﬁed as either major
(Class I) or moderate (Class II) muscle detachment phenotypes, present
in msk mutant embryos is likely due to the presence of maternal msk
transcript. Attempts to further knockdownMsk levels by removal ofma-
ternal load resulted in non-viable egg chambers, consistent with a re-
quirement for Msk function in cell viability (Johnson Hamlet and
Perkins, 2001). It is possible that a further decrease, but not complete
loss in Msk function, could result in earlier defects in myogenesis as
we observed muscle patterning defects, predominantly characterized
by missing muscles, in a subset of msk mutant embryos (12.1% in
msk2/msk4 and 12.5% in msk4/msk5 trans-heterozygous combinations).
Late tendon cell differentiation and/or maintenance are affected in msk
mutants
After cell fate determination is established in somatic muscle de-
velopment, myoblast fusion and myotube migration begin to proceed
simultaneously in stage 13 embryos until the ﬁnal muscle pattern is
completed (Schnorrer and Dickson, 2004). As the migrating myo-
tubes approach their target tendon cells, the αPS2βPS integrin het-
erodimer begins to accumulate at the leading edge of the muscle.
This integrin complex is required for at least two separate events:
(1) to serve as a transmembrane link between the internal actin cyto-
skeleton and the ECM components Tsp and Tig (Schweitzer et al.,
2010); and (2) for the proper localization and/or accumulation of
Vein (Yarnitzky et al., 1997). The accumulation of Vein at the sites
of muscle–tendon interactions is necessary for activation of the Egfr
pathway and subsequent late tendon cell differentiation. In these
mature, muscle-linked tendon cells, SrB expression is positively regu-
lated. SrB also turns on the downstream transcriptional target Tsp,
resulting in more Tsp secretion and subsequent strengthening of the
MTJ through integrin binding (Schweitzer et al., 2010).
Our results suggest that Msk affects the later stages of tendon cell
maturation and MTJ formation and/or maintenance. First, we did not
observe any obvious defects in myoblast fusion or the guidance of mus-
cles to their correct target tendon cell. Furthermore, Msk protein ex-
pression, visualized by both antibody immunolocalization and a
ﬂuorescently-taggedMsk fusion protein, demonstrates that enrichment
of Msk protein at the future muscle–tendon attachment sites occurs
after stage 15. The appearance of Msk protein localization corresponds
to the timing ofMTJ junction formation, but it does not rule out the pos-
sibility that Msk has a role in earlier myogenic events. Third, themuscle
detachment phenotypes observed in msk mutant embryos are consis-
tent with themyospheroid phenotype observed for other genes, includ-
ing myospheroid (βPS int), inﬂated (αPS2 int), and rhea (Talin), which
are well-characterized for their role in embryonic muscle attachment
(Brown, 1994; Brown et al., 2002; Leptin et al., 1989; Newman and
Wright, 1981). Finally, in all msk mutants examined, regardless of the
severity of themuscle detachment phenotypes,MTJ formation occurred
in the correct location. Although the muscle attachment sites were
smaller inmskmutants than inWT embryos, they were initially formed
correctly, but not capable of reaching theirmature size. These data taken
together indicate that the muscle-speciﬁc αPS2βPS integrin complex
initially forms an attachment to the ECMproteins Tig and Tsp. However,
as mature tendon cell induction is compromised inmskmutant embry-
os, whereby the tendon cells are not able to produce and secrete proper
levels of Tsp protein. Thus, the size of thematureMTJ is reduced and re-
sults in a decreased afﬁnity at the muscle–tendon junctions.
Sr is a key factor in tendon cell differentiation in the embryo and
ﬂy thorax (Fernandes et al., 1996; Frommer et al., 1996; Volk and
VijayRaghavan, 1994). In the embryo, SrB is essential for early tendon
cell induction and SrA is activated for later tendon cell maturation(Volohonsky et al., 2007). Furthermore, ectopic expression of Sr can
act as a guidance cue for migrating myotubes as ectopic expression
of Sr in epidermal cells, the salivary glands, or the CNS results in mus-
cle patterning defects where muscles take the incorrect route and/or
become attached to ectopic cells expressing Sr (Becker et al., 1997;
Vorbruggen and Jackle, 1997). Even though our data shows that
Msk is required for nuclear Sr in the tendon cells, ectopic expression
of Msk is not sufﬁcient for tendon cell induction based upon three
lines of experimentation. First, ectopic Msk expression in either the
muscle or epidermis resulted in aberrant muscle attachment, but
not misguided myotubes. All muscles were found to be in the correct
position, regardless of Msk expression in domains outside of the
normal hemisegments. Second, ectopic Msk expression was not sufﬁ-
cient to induce either early or elevated Sr levels. Third, expression of
Msk in the salivary glands or CNS did not result in misguided muscles
toward these locations.
Role of Msk in FAK-mediated integrin adhesion and tendon cell signaling
Our tissue-speciﬁc rescue experiments show that Msk is required
in the muscle cell for proper muscle–tendon attachment to occur.
Thus, we propose twomechanisms, which are not mutually exclusive,
by whichMskmay be functioning in the muscle cells to exert its effect
on tendon cell maturation (Fig. 10). First, Mskmay be required direct-
ly and/or indirectly for the localization and/or accumulation of secret-
ed Vein. As antibodies against Vein were not available for us to test
this possibility, we showed that reintroducing Vein in msk mutants
could rescue muscle attachment defects. Second, Msk may act via an
integrin-dependent mechanism to modulate adhesion, which is
explained in detail below.
From our studies, Msk localizes to the ends of muscles at the sites of
muscle attachment. We propose that this localization of Msk recruits
other proteins to the sites of muscle attachment to sequester proteins
near the cell periphery and/or tomodulate integrin afﬁnity at themuscle
attachment site. First, the absence of pFAK localization in msk mutants
strongly suggests that Msk is essential for pFAK localization to themus-
cle–tendon attachment site. Surprisingly, mutations in FAK do not result
in embryonicmuscle attachment defects (Grabbe et al., 2004). However,
pFAK localization is also lost in integrinmutants, suggesting that pFAK is
involved in undeﬁned events in myogenesis. If Msk serves as a scaffold
protein to localize pFAK and/or other molecules to the sites of muscle–
tendon cell attachment, these proteins may play an accessory role in
integrin-mediated adhesion. One idea is that a Msk-pFAK complex
may serve to limit the signaling function of integrins so its adhesive
role predominates in MTJ formation. It is well-established that integrins
play both adhesive and signaling roles in cell migration and develop-
ment (Brower, 2003; Pinon and Wehrle-Haller, 2011). Clustering of
the cytoplasmic tails of βPS-integrins initiates a downstream signaling
pathway that regulates gene expression in the Drosophila midgut, but
is not sufﬁcient to induce tendon cell differentiation in formation of
the MTJ (Martin-Bermudo et al., 1999). This suggests that integrin-
mediated adhesion is required to assemble ECM components and inﬂu-
ence the ability of Vein to activate the Egfr pathway. While loss of FAK
activity does not result in somatic muscle defects, overexpression of
FAK does. Muscles that have detached from the epidermis as a result
of FAK overexpression still retain αPS2 integrins at the muscle ends
(Grabbe et al., 2004). As observed in mammalian systems, this raises
the possibility that pFAK may play a role in integrin complex disassem-
bly. Excess pFAK may either displace proteins that bind to the
cytoplasmic domain of integrins or excessively phosphorylate proteins
resulting in integrin complex turnover and a decrease in stable adhesion.
Alternatively, pFAKmay exhibit redundancywith another protein at the
attachment sites. There is precedence for this in theﬂy as pFAK functions
redundantly with the tyrosine kinase Src downstreamof integrins in the
larval neuromuscular junctions (NMJs) to restrict NMJ growth (Tsai et
al., 2008). Furthermore, in FAK mutants, phosphotyrosine signal is still
188 Z.(C.) Liu, E.R. Geisbrecht / Developmental Biology 359 (2011) 176–189observed at the sites of muscle attachment (Grabbe et al., 2004), sup-
porting the idea that another tyrosine kinase is functional. A viable can-
didate may be Src42A, as it is also expressed at the sites of muscle
attachment in the embryo (Takahashi et al., 2005).
The canonical role for Msk is to import proteins, such as activated
MAPK into the nucleus. However, we did not detect activated MAPK
or nuclear Msk in the nuclei of muscle cells. As we showed in Fig. 4,
we detected strong Msk immunolocalization at the MTJ in stage 16
embryos, but not in the nuclei of developing muscles in stages
13–15. We cannot rule out the possibility that Msk is present at low
levels in the muscle and we were not able to detect it. It is true that
we can see our YFP-Msk fusion protein in the nucleus (Figs. 4G, H),
but this may be due to the over-expression of our protein. While it
is possible that nuclear Msk and MAPK in muscles are required for
some aspects of myogenesis, this requires further analysis.
Future experiments will determine the precise mechanism by
which Msk inﬂuences Vein secretion, localization, and/or accumula-
tion at muscle–tendon cell attachment sites. Is it mediated through
integrins? Is phosphorylation of Msk essential for activity? Msk is
tyrosine phosphorylated in response to insulin and PS integrins,
although the kinase remains unknown. FAK may be an example of a
kinase that can phosphorylate Msk at the muscle attachment sites.
Inmammalian studies, the canonical role for Importin-7 is in nuclear
import. To our knowledge, other roles for cytoplasmic Importin-7 have
not been examined. Thus, it will be interesting to uncover new roles for
Importin-7, speciﬁcally in vertebrate muscle development.
Supplementary materials related to this article can be found online
at doi:10.1016/j.ydbio.2011.08.028.
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